Onderneming TearLab Corp Nasdaq
Aandelen
US8781932004
Medische apparatuur, benodigdheden & distributie
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Adam Szaronos
CEO | Chief Executive Officer | - | 09-12-21 |
Founder | - | 01-01-96 | |
John Lund
DFI | Director of Finance/CFO | 58 | 01-07-22 |
Steve Zmina
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-06 |
Sam Fakhoury
COO | Chief Operating Officer | - | 01-12-14 |
Michael Berg
CTO | Chief Tech/Sci/R&D Officer | 71 | 01-01-06 |
Uri Geiger
BRD | Director/Board Member | 56 | 09-07-20 |
John Steenbakker
SAM | Sales & Marketing | - | 01-10-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 76 | 01-09-04 | |
James V. Mazzo
CHM | Chairman | 66 | 09-11-21 |
Uri Geiger
BRD | Director/Board Member | 56 | 09-07-20 |
Barak Azmon
BRD | Director/Board Member | - | - |
Dolev Rafaeli
BRD | Director/Board Member | 60 | - |
David Carter
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 24 410 766 | 12 213 308 ( 50,03 %) | 0 | 50,03 % |
Bedrijfsgegevens
TearLab Corporation, Inc.
940 South Kimball Avenue
76092, Southlake
+855-832-7522
http://www.tearlab.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,09% | 44,27 mld. | |
-7,01% | 17,76 mld. | |
-27,37% | 1,93 mld. | |
+11,84% | 1,87 mld. | |
+21,69% | 1,16 mld. | |
+75,35% | 659 mln. | |
-9,57% | 634 mln. | |
-44,04% | 633 mln. | |
-45,65% | 604 mln. |